DK1915171T3 - Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler - Google Patents

Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler

Info

Publication number
DK1915171T3
DK1915171T3 DK06789148.1T DK06789148T DK1915171T3 DK 1915171 T3 DK1915171 T3 DK 1915171T3 DK 06789148 T DK06789148 T DK 06789148T DK 1915171 T3 DK1915171 T3 DK 1915171T3
Authority
DK
Denmark
Prior art keywords
insulin
producing cells
function
keeping
procedure
Prior art date
Application number
DK06789148.1T
Other languages
Danish (da)
English (en)
Inventor
Anders Hasager Boss
Wayman Wendell Cheatham
David C Diamond
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Application granted granted Critical
Publication of DK1915171T3 publication Critical patent/DK1915171T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06789148.1T 2005-08-01 2006-08-01 Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler DK1915171T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70429505P 2005-08-01 2005-08-01
PCT/US2006/030014 WO2007016600A2 (en) 2005-08-01 2006-08-01 Method of preserving the function of insulin-producing cells

Publications (1)

Publication Number Publication Date
DK1915171T3 true DK1915171T3 (da) 2013-12-09

Family

ID=37561086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06789148.1T DK1915171T3 (da) 2005-08-01 2006-08-01 Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler

Country Status (10)

Country Link
EP (1) EP1915171B1 (cg-RX-API-DMAC7.html)
JP (2) JP2009503093A (cg-RX-API-DMAC7.html)
CN (1) CN101232899A (cg-RX-API-DMAC7.html)
AU (1) AU2006275424B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614489A2 (cg-RX-API-DMAC7.html)
CA (1) CA2617226A1 (cg-RX-API-DMAC7.html)
DK (1) DK1915171T3 (cg-RX-API-DMAC7.html)
ES (1) ES2439455T3 (cg-RX-API-DMAC7.html)
MX (1) MX2008001643A (cg-RX-API-DMAC7.html)
WO (1) WO2007016600A2 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
IN2014DN09128A (cg-RX-API-DMAC7.html) 2005-09-14 2015-07-10 Mannkind Corp
CN101389348A (zh) 2006-02-22 2009-03-18 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
CN109568740B (zh) 2008-06-13 2022-05-27 曼金德公司 干粉吸入器和用于药物输送的系统
BR122020002400B1 (pt) 2008-06-20 2021-12-07 Mannkind Corporation Sistema de detecção de inalação de pó seco e sistema de monitoramento acoplável para um inalador de pó seco
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
JP5918539B2 (ja) * 2009-01-08 2016-05-18 マンカインド コーポレイション Ｇｌｐ−１を用いる高血糖症の治療方法
KR101733816B1 (ko) * 2009-03-04 2017-05-08 맨카인드 코포레이션 개선된 건조 분말 약물 전달 시스템
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
CA2764505C (en) 2009-06-12 2018-09-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
MX392016B (es) 2013-03-15 2025-03-21 Mannkind Corp Composiciones de dicetopiperazina microcristalina y métodos.
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
AU2015339576B2 (en) 2014-10-27 2020-02-06 Glytec, Llc Subcutaneous outpatient management
JP7109155B2 (ja) 2015-06-04 2022-07-29 キッコーマン株式会社 フラビン結合型グルコースデヒドロゲナーゼを用いたグルコースの測定方法
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
CN110187123B (zh) * 2019-05-06 2022-07-22 天津医科大学总医院 一种糖尿病早期诊断生物标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ500075A (en) * 1997-04-02 2001-03-30 Purdue Research Foundation Method for the oral delivery of a protein encapsulated within a hydrogel matrix
CA2377204C (en) * 1999-06-29 2015-01-20 Pharmaceutical Discovery Corporation Purification and stabilization of peptide and protein pharmaceutical agents
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
AU2004220544B2 (en) * 2003-03-06 2010-06-17 Emisphere Technologies, Inc. Oral insulin therapies and protocol
ES2584867T3 (es) * 2004-01-12 2016-09-29 Mannkind Corporation Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2

Also Published As

Publication number Publication date
JP2009503093A (ja) 2009-01-29
EP1915171A2 (en) 2008-04-30
ES2439455T3 (es) 2014-01-23
JP2015091854A (ja) 2015-05-14
BRPI0614489A2 (pt) 2011-03-29
WO2007016600A2 (en) 2007-02-08
AU2006275424A1 (en) 2007-02-08
EP1915171B1 (en) 2013-11-20
AU2006275424B2 (en) 2013-01-10
MX2008001643A (es) 2008-04-07
CA2617226A1 (en) 2007-02-08
WO2007016600A3 (en) 2007-05-31
CN101232899A (zh) 2008-07-30

Similar Documents

Publication Publication Date Title
DK1915171T3 (da) Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler
NL301145I2 (nl) Tirbanibulin
MX2008006589A (es) Composiciones de edulcorante natural de mesa, de alta potencia, con perfil temporal y/o de sabor mejorado, metodos para su formulacion, y usos
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
DK2321321T3 (da) Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
AR069474A1 (es) Material anticorrosivo
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
JP2007525551A5 (cg-RX-API-DMAC7.html)
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
ECSP088692A (es) Compuestos basados en imidazol, composiciones que comprenden a los mismos y métodos de su uso
CL2010001483A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune.
BRPI0516257A (pt) composição de gordura, método para a preparação de mesa, e, uso de uma composição de gordura
SV2008002906A (es) Metodos y composiciones para modular la hemostasiaref. cho.0267b-sv
AR053827A1 (es) Composiciones de tigeciclina y metodos de preparacion
BRPI0511396A (pt) derivados de retinal e métodos para uso no tratamento de enfermidades visuais
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
ECSP099675A (es) Compuestos heterocíclicos, composición y métodos de uso
ITTO20040390A1 (it) Composizione, in particolare per uso farmaceutico, ad azione antiossidante, antinfiammatoria ed immunostimolante.
NO20075368L (no) Antiinflammatoriske modaliteter
UY30214A1 (es) Modificaciones de ( 5s) -5-(4-(5-cloro-piridin--2-iloxi)-piperidina-1-sulfonilmetil)-5-metil-imidazolidina-2,4-diona, procesos para su preparacion, composiciones que los contengan y aplicaciones.
ATE443463T1 (de) Regal-fachboden
DK1907561T3 (da) Cellelinjer til ekspression af enzym, der er anvendeligt i fremstillingen af amiderede produkter
UY29440A1 (es) Nuevos compuestos